Department of Neurology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Yuzhong District, Chongqing, PR China.
PLoS One. 2013;8(2):e56478. doi: 10.1371/journal.pone.0056478. Epub 2013 Feb 11.
Epidemiological studies have evaluated the association between nicotinamide adenine dinucleotide phosphate (NADPH) oxidase p22(phox) C242T polymorphism and risk of ischemic cerebrovascular disease (ICVD), but the results remain inconclusive. This meta-analysis was therefore designed to clarify these controversies.
METHODOLOGY/PRINCIPAL FINDINGS: Systematic searches of electronic databases Embase, PubMed and Web of Science, as well as hand searching of the references of identified articles and the meeting abstracts were performed. Statistical analyses were performed using software Review Manager (Version 5.1.7) and Stata (Version 11.0). The pooled odds ratios (ORs) with 95% confidence intervals (95%CIs) were performed. Fixed or random effects model was separately used depending on the heterogeneity between studies. Publication bias was tested by Begg's funnel plot and Egger's regression test. A total of 6 studies including 1,948 cases and 2,357 controls were combined showing no statistical evidence of association between NADPH oxidase p22(phox) C242T polymorphism and overall ICVD (allelic model: OR = 1.08, 95%CI = 0.93-1.26; additive model: OR = 1.33, 95%CI = 0.81-2.17; dominant model: OR = 1.00, 95%CI = 0.86-1.15; recessive model: OR = 1.06, 95%CI = 0.77-1.45). Significant association was found in large-artery atherosclerotic stroke subgroup (allelic model: OR = 1.12, 95%CI = 0.88-1.41; additive model: OR = 1.36, 95%CI = 0.60-3.09; dominant model: OR = 1.25, 95%CI = 0.74-2.11; recessive model: OR = 2.17, 95%CI = 1.11-4.23). No statistical evidence of significant association was observed for small-vessel occlusive stroke, as well as Asian subgroup and Caucasian subgroup. Statistical powers on the combined sample size (total and subgroup) were all lower than 80%.
CONCLUSIONS/SIGNIFICANCE: This meta-analysis indicates that NADPH oxidase p22(phox) C242T polymorphism is more associated with large-artery atherosclerotic stroke than small-vessel occlusive stroke. However, this conclusion should be interpreted with caution due to the small sample size. Larger sample-size studies with homogeneous ICVD patients and well-matched controls are required.
流行病学研究评估了烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶 p22(phox)C242T 多态性与缺血性脑血管病(ICVD)风险之间的关系,但结果仍存在争议。因此,本荟萃分析旨在阐明这些争议。
方法/主要发现:系统检索了 Embase、PubMed 和 Web of Science 电子数据库,以及对已确定文章的参考文献和会议摘要进行了手工检索。使用软件 Review Manager(版本 5.1.7)和 Stata(版本 11.0)进行统计分析。使用 95%置信区间(95%CI)进行合并的优势比(OR)。根据研究之间的异质性,分别使用固定或随机效应模型。通过 Begg 漏斗图和 Egger 回归检验测试发表偏倚。共有 6 项研究,包括 1948 例病例和 2357 例对照,合并后无 NADPH 氧化酶 p22(phox)C242T 多态性与总体 ICVD 之间存在统计学关联的证据(等位基因模型:OR=1.08,95%CI=0.93-1.26;加性模型:OR=1.33,95%CI=0.81-2.17;显性模型:OR=1.00,95%CI=0.86-1.15;隐性模型:OR=1.06,95%CI=0.77-1.45)。在大动脉粥样硬化性卒中亚组中发现了显著的关联(等位基因模型:OR=1.12,95%CI=0.88-1.41;加性模型:OR=1.36,95%CI=0.60-3.09;显性模型:OR=1.25,95%CI=0.74-2.11;隐性模型:OR=2.17,95%CI=1.11-4.23)。在小血管闭塞性卒中亚组以及亚洲亚组和高加索亚组中,没有观察到与 NADPH 氧化酶 p22(phox)C242T 多态性显著相关的统计学证据。基于合并样本量(总体和亚组)的统计效能均低于 80%。
结论/意义:本荟萃分析表明,NADPH 氧化酶 p22(phox)C242T 多态性与大动脉粥样硬化性卒中的相关性大于小血管闭塞性卒中。然而,由于样本量较小,这个结论应该谨慎解释。需要对具有同质 ICVD 患者和匹配良好对照的更大样本量研究进行研究。